MyoKi

MyoKi is a peptide-based nutraceutical developed by Caregen to support muscle health, nutritional balance, and functional performance. It is designed to help maintain lean muscle mass and support muscle metabolism, making it relevant for both aging populations and active individuals seeking improved body composition. As a food supplement, MyoKi contributes to health and nutrition by supporting muscle maintenance, which is essential for metabolic balance, physical strength, and overall vitality. It is particularly relevant in weight management, where preservation of lean mass is critical for sustainable outcomes. MyoKi completed the U.S. FDA New Dietary Ingredient (NDI) notification in February 2025, supporting its global regulatory positioning within the health nutrition category. <Clinical Results> - In a clinical study involving 80 sarcopenia patients, MyoKi increased Skeletal Muscle Mass (2.52%), Lean Muscle Mass (2.56%), Grip Strength (5.6–6.2%), and 6-Meter Walk Test performance (12.4%). Biomarker validation showed increased anabolic signals and decreased catabolic markers. These results indicate that MyoKi supports muscle regeneration and functional strength while helping preserve muscle mass during weight management and healthy aging. MyoKi is positioned as a science-based solution for muscle performance and preservation. It supports muscle-related metabolic balance and physical capability. Key target segments include aging populations, individuals undergoing weight management, and active consumers seeking strength, recovery, and lean mass preservation. MyoKi represents a differentiated nutraceutical solution aligned with growing demand for preventive muscle health management.